Larry E. Douglass
Impact in
-
- PI3K/AKT/mTOR signaling in cancer
- Polyamine Metabolism and Applications
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
- RNA Research and Splicing
- TGF-β signaling in diseases
- Cancer-related gene regulation
- Protein Kinase Regulation and GTPase Signaling
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 3
- TGF-β signaling in diseases 2
- Renal and related cancers 1
- Cancer-related gene regulation 1
-
- Cancer Mechanisms and Therapy 1
- Co-authors
- Julia H. Carter (6 shared papers)James A. Deddens (6 shared papers)Jeremy Richard Graff (5 shared papers)Bruce M. Colligan (5 shared papers)Jackson O. Pemberton (5 shared papers)Mark S. Marshall (1 shared paper)Joanne T. Hom (1 shared paper)David R. Weber (1 shared paper)
- Journals
- Cancer Research (2 papers)British Journal of Cancer (2 papers)Clinical Cancer Research (2 papers)International Journal of Cancer (1 paper)The American Journal of Medicine (1 paper)
- Partner nations
- United StatesVietnam
In The Last Decade
Larry E. Douglass
9 papers receiving 854 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 654
- Cancer Research 94
- Oncology 156
- Immunology and Allergy 26
- Immunology 90
Countries citing papers authored by Larry E. Douglass
This map shows the geographic impact of Larry E. Douglass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry E. Douglass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry E. Douglass more than expected).
Fields of papers citing papers by Larry E. Douglass
This network shows the impact of papers produced by Larry E. Douglass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry E. Douglass. The network helps show where Larry E. Douglass may publish in the future.
Co-authors
The 25 scholars most cited alongside Larry E. Douglass, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 327 | |
| 2 | 2009 | 171 | |
| 3 | 2004 | 153 | |
| 4 | 1969 | 54 | |
| 5 | 2006 | 41 | |
| 6 | 2016 | 41 | |
| 7 | 2004 | 36 | |
| 8 | 2016 | 33 | |
| 9 | 2018 | 27 |
About Larry E. Douglass
Larry E. Douglass is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Gastroenterology, Immunology and Allergy and Immunology, having authored 9 papers that have together received 883 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (3 papers), TGF-β signaling in diseases (2 papers), Cancer Mechanisms and Therapy (1 paper), Mast cells and histamine (1 paper), Renal and related cancers (1 paper), Cell Adhesion Molecules Research (1 paper), Gastric Cancer Management and Outcomes (1 paper) and Cancer-related gene regulation (1 paper). The work is most often cited by research in Molecular Biology (654 citations), Cancer Research (94 citations), Oncology (156 citations), Immunology and Allergy (26 citations) and Immunology (90 citations). Larry E. Douglass has collaborated with scholars based in United States and Vietnam. Frequent co-authors include Julia H. Carter, James A. Deddens, Jeremy Richard Graff, Bruce M. Colligan, Jackson O. Pemberton, Mark S. Marshall, Joanne T. Hom, David R. Weber, Stephen H. Parsons and Chad A. Dumstorf. Their work appears in journals such as Cancer Research, British Journal of Cancer, Clinical Cancer Research, International Journal of Cancer and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.